Published in
Elsevier, European Urology, (81), p. S807-S808, 2022
DOI: 10.1016/s0302-2838(22)00619-4
Links
Tools
Predictors of phosphodiesterase type 5 Inhibitors (PDE5I)-discontinuation - Is a previous PDE5I-exposure at first clinical evaluation related with a higher PDE5I-drop-out risk?
Journal article published in 2022 by
N. Schifano,
P. Capogrosso,
G. Fallara,
E. Pozzi 
,
F. Belladelli,
L. Candela,
C. Corsini,
M. Raffo,
A. Costa,
D. Cignoli,
A. D'Arma,
L. Boeri,
E. Ventimiglia,
R. Matloob,
V. Mirone
and other authors.
,
F. Belladelli,
L. Candela,
C. Corsini,
M. Raffo,
A. Costa,
D. Cignoli,
A. D'Arma,
L. Boeri,
E. Ventimiglia,
R. Matloob,
V. Mirone
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 